At a glance
ClinicalIndex Comparison RecordN/ACompleted· 664 enrolled
Drug / intervention
MarginProbe +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery
In Brief
A clinical study evaluating MarginProbe and Lumpectomy for Breast Cancer. Completed, enrolled 664 participants across 21 sites in 2 countries.
Detailed Summary
The purpose of this study is to show that addition of device use to a routine breast cancer tumor excision procedure is beneficial and assists the surgeon in correctly determining the extent of excision.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesIsrael, United States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2008
Enrollment StartOct 2008
Primary CompletionMar 2010
Study CompletionJun 2010
TodayJul 2026
First PostedSep 9, 2008
Enrollment StartOct 1, 2008
Primary CompletionMar 1, 2010
Study CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 17.8 years ago
Interventions
MarginProbedevice
Device use to assess margin status of the excised specimen surface.
Lumpectomyprocedure
Standard of care lumpectomy procedure